169249-10-9 Usage
Uses
Used in Pharmaceutical Industry:
(+)-trans-N-[1-(4-chloro-3-methoxy-phenyl)-1,2,3,4-tetrahydronaphthalen-2-yl]-methylamine is used as a potential pharmaceutical agent for its unique chemical and biological properties. (+)-trans-N-[1-(4-chloro-3-methoxy-phenyl)-1,2,3,4-tetrahydronaphthalen-2-yl]-methylamine's complex structure may allow it to interact with biological systems in ways that could be harnessed for therapeutic purposes, such as targeting specific receptors or enzymes involved in disease processes.
Used in Chemical Research:
In the field of chemical research, (+)-trans-N-[1-(4-chloro-3-methoxy-phenyl)-1,2,3,4-tetrahydronaphthalen-2-yl]-methylamine serves as a subject of study for understanding the effects of chirality and functional groups on compound behavior. Its unique structure may provide insights into the development of new synthetic pathways or the discovery of novel chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 169249-10-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,2,4 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 169249-10:
(8*1)+(7*6)+(6*9)+(5*2)+(4*4)+(3*9)+(2*1)+(1*0)=159
159 % 10 = 9
So 169249-10-9 is a valid CAS Registry Number.
169249-10-9Relevant academic research and scientific papers
Catalytic enantioselective synthesis of the dopamine D1 antagonist ecopipam
Hajra, Saumen,Bar, Sukanta
, p. 151 - 156 (2012/06/16)
A concise asymmetric synthesis of the potent dopamine D1 antagonist, ecopipam, has been accomplished in six steps with 33% overall yield via catalytic enantioselective aziridination and subsequent one-pot Friedel-Crafts cyclization of an in situ generated tethered aziridine with high diastereo- and enantioselectivities.
Novel stereoselective syntheses of the fused benzazepine dopamine D1 antagonist (6as,13br)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5h-benzo[d]naphth[2,1-b] azepin-12-ol (sch 39166): 2. l-homophenylalanine-based syntheses
Draper, Richard W.,Hou, Donald
, p. 186 - 193 (2013/09/08)
Two enantioselective syntheses of the fused benzazepine dopamine D1 antagonist (6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b] azepin-12-ol (1) are described in which the starting material is (+)-L-homophenylalan
